A mbulatory blood pressure monitoring not only provides information on the blood pressure level, but on changes in blood pressure as well. Blood pressure variability is a multifaceted phenomenon that includes both short-term and long-term components, which can be estimated by the standard deviation of the blood pressure values over a defined period of the day or by the night-to-day blood pressure ratio, respectively. Type 2 diabetic patients often have a dysregulation of the autonomic control of cardiovascular function, which is bound to increase blood pressure variability. 1 In this issue of the Journal, 2 Eguchi et al. reported that among 300 Japanese patients with uncomplicated type 2 diabetes, the shortterm night time blood pressure variability, as exemplified by the standard deviation of systolic or diastolic blood pressure during sleep, predicted a composite cardiovascular end point consisting of stroke, not including transient ischemic attack, myocardial infarction, and sudden cardiac death. With adjustments applied for age, smoking, and the level of blood pressure, on either conventional or 24-h or night time ambulatory measurement, 2 shortterm blood pressure variability during sleep remained a significant predictor of outcome. This was not the case for shorttime blood pressure variability during the awake period of the day, the morning surge in blood pressure, and long-term blood pressure variability as reflected by dipping status. Strong points of Eguchi's study are that the patients were off medication (95% for 2 weeks) at the time of the ambulatory blood pressure recording and that the composite cardiovascular end point included only hard events, which were properly adjudicated. 2 Of concern is the power of a study with only 29 cardiovascular events, the collinearity between explanatory variables in the Cox model, and the fact that the low number of end points made proper estimates of multivariable-adjusted hazard ratios impossible. For instance, the models did not include sex, body mass index, or serum creatinine. The qualifier strong in the title of Eguchi's article might therefore be a misnomer.
Assessment of the prognostic significance of blood pressure variability is difficult. There is strong association between the level and the variability of blood pressure. Collinearity between these two variables may cause problems in building stable regression models. Physical activity and emotional stimuli cannot be standardized and explain the low reproducibility of measures of blood pressure variability. 3 It does therefore not come as a surprise that in Eguchi's study blood pressure variability during sleep, but not during daytime, predicted outcome. Furthermore, increased blood pressure variability often clusters with established cardiovascular risk factors, such as older age, hypertension, and diabetes mellitus, which makes disentangling their independent effects on outcome a daunting task. 4 Target organ damage, arterial stiffening, dysfunction of the autonomous nervous system, and impairment of the baroreflex are all forerunners of cardiovascular complications, but at the same time increase blood pressure variability. 4 This raises the issue of reverse causality, increased blood pressure variability being a marker of underlying disease rather than an independent predictor of imminent cardiovascular events. Among 7,458 subjects randomly recruited from six populations, 5 those with higher night time than daytime blood pressure had a higher risk of death. However, reverse dippers were more frequently on antihypertensive drug treatment, were also older, and more often had a history of diabetes mellitus or previous cardiovascular disease. 5 In the same database, we could not confirm the prognostic significance of the morning surge in blood pressure. In comparison with crosssectional observations, prospective outcome studies, such as Eguchi's report, 2 can partially address confounding and reverse causality, but they cannot completely remove this problem. Finally, the accurate assessment of the prognostic meaning of blood pressure variability might require beat-to-beat blood pressure recordings analyzed in the frequency domain rather than over time. The Northwick Park study 6 included 479 hypertensive patients, who all underwent 24-h continuous intra-arterial blood pressure measurement. After 9.1 years of follow-up, blood pressure variability, as assessed by hourly standard deviations, the nocturnal fall in blood pressure and dipping status, did not predict coronary 
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or cerebrovascular events in multivariable-adjusted analyses. 6 To our knowledge, the Northwick Park recordings were not analyzed in the frequency domain. 6 Noninvasive approaches currently replace the invasive intra-arterial technique, but to our knowledge no large-scale population studies with outcome data based on continuous recordings are currently available. Thus, for now, blood pressure variability remains an elusive prognostic index.
